ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.

Veryan Medical, a UK-based vascular implant spinout from Imperial College London, has been acquired by medical device manufacturer Otsuka Medical Devices for an undisclosed exit, allowing commercialisation firm IP Group to exit.
Founded in 2003, Veryan has devised a vascular flow stent with a 3D helical shape designed to reflect natural curvatures in the body’s arterial system.
The stent, dubbed Swirling Flow, is intended to treat peripheral vascular disease by improving blood circulation to the target area while strengthening the interface between circulating blood and the rest of the vessel wall, a grouping of cells known as the endothelium.
Swirling Flow was approved by US regulator Food and Drug Administrator in October 2018. Following the close of the deal, Otsuka Medical will collaborate with Veryan on product development, and Otsuka also intends to maintain the company’s offices in Galway, Ireland.
Veryan had raised approximately $56m in…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?